Pharma Foods International Co., Ltd. provided consolidated earnings guidance for the year ending July 31, 2023. For the year, the company expects net sales of ¥71,000 million, operating profit of ¥1,191 million, profit attributable to owners of the parent of ¥886 million, and earnings per share of ¥30.47.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
870 JPY | -1.47% | -0.23% | -13.17% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.17% | 159M | |
+44.48% | 55.07B | |
+43.51% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- 2929 Stock
- News Pharma Foods International Co., Ltd.
- Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2023